An Unusual Case Of Hemorrhagic Pleuropericarditis After COVID-19 Vaccination

  • Javed A
  • Medina Y
  • Tian J
  • et al.
N/ACitations
Citations of this article
11Readers
Mendeley users who have this article in their library.

Abstract

As coronavirus disease 2019 (COVID-19) vaccines are being increasingly administered worldwide, subsequent side effects, such as myocarditis, pericarditis, and myopericarditis, are becoming increasingly more common. Our case describes a 64-year-old male who developed chest pain and shortness of breath one week after receiving the Moderna (Cambridge, Massachusetts) COVID-19 mRNA vaccine. He was found to have a large, left-sided pleural effusion and a small pericardial effusion. The patient underwent thoracentesis and video-assisted thoracoscopic procedure with chest tube placement, which drained bloody pleural and pericardial fluid. He was treated with a course of colchicine. Subsequent imaging revealed the resolution of pericardial and pleural effusions, along with the resolution of symptoms.

Cite

CITATION STYLE

APA

Javed, A., Medina, Y., Tian, J., Alvi, M. J., Sahra, S., & Rojas-Marte, G. (2022). An Unusual Case Of Hemorrhagic Pleuropericarditis After COVID-19 Vaccination. Cureus. https://doi.org/10.7759/cureus.24828

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free